TY - JOUR
T1 - Quality of life in sexually active men with symptomatic benign prostatic hyperplasia
T2 - Effects of treatment
AU - Daly, Mel P.
N1 - Funding Information:
This work was supported in part by a grant from Sanofi-Synthelabo Inc. The authors have no potential conflicts of interest that are directly relevant to the contents of this manuscript.
PY - 2005
Y1 - 2005
N2 - Quality of life (QOL), sexuality in particular, has become an important consideration in treatment decisions for men with lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). To determine the impact of these conditions on sexual function and QOL in older men, this article provides a review of clinical data on the relationship between sexual dysfunction and symptom severity, effective clinical assessment, treatment options, and the influence of current therapies on sexual function and QOL. The various symptoms of BPH can adversely affect sexual functioning and therefore QOL. Moreover, there may be a direct association between symptom severity and sexual dysfunction that may affect QOL. Patients base their decisions regarding treatment choices for BPH more on anticipated relief of lower urinary tract symptoms and improved QOL (including sexual functioning) than on improvements in physical measures. Although medications and surgery may relieve LUTS, sexual dysfunction is a common adverse result. Newer pharmacological interventions such as specific α-adrenergic blocking agents like tamsulosin may help improve sexual function and QOL in men with symptomatic BPH.
AB - Quality of life (QOL), sexuality in particular, has become an important consideration in treatment decisions for men with lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). To determine the impact of these conditions on sexual function and QOL in older men, this article provides a review of clinical data on the relationship between sexual dysfunction and symptom severity, effective clinical assessment, treatment options, and the influence of current therapies on sexual function and QOL. The various symptoms of BPH can adversely affect sexual functioning and therefore QOL. Moreover, there may be a direct association between symptom severity and sexual dysfunction that may affect QOL. Patients base their decisions regarding treatment choices for BPH more on anticipated relief of lower urinary tract symptoms and improved QOL (including sexual functioning) than on improvements in physical measures. Although medications and surgery may relieve LUTS, sexual dysfunction is a common adverse result. Newer pharmacological interventions such as specific α-adrenergic blocking agents like tamsulosin may help improve sexual function and QOL in men with symptomatic BPH.
UR - http://www.scopus.com/inward/record.url?scp=17844392860&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17844392860&partnerID=8YFLogxK
U2 - 10.2165/00044011-200525040-00001
DO - 10.2165/00044011-200525040-00001
M3 - Review article
C2 - 17523772
AN - SCOPUS:17844392860
SN - 1173-2563
VL - 25
SP - 219
EP - 230
JO - Clinical Drug Investigation
JF - Clinical Drug Investigation
IS - 4
ER -